Loading...
Loading...
Santarus
SNTS surged 37.38% to $31.90 in the pre-market session. Santarus and Pharming announced new data from open-label repeat treatment study with RUCONEST. Piper Jaffray downgraded Santarus from Overweight to Neutral.
Universal Display
OLED shares jumped 16.64% to $34 in pre-market trading after the company reported upbeat Q3 results and issued a strong FY13 revenue forecast.
Horizon Pharma
HZNP shares gained 14.97% to $4.30 in the pre-market session on Q3 results.
Ubiquiti Networks
UBNT soared 13.64% to $42.25 in the pre-market trading on stronger-than-expected Q1 results.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
